Endocan or endothelial cell specific molecule-1 (ESM-1): A potential novel endothelial cell marker and a new target for cancer therapy

2006 ◽  
Vol 1765 (1) ◽  
pp. 25-37 ◽  
Author(s):  
S. Sarrazin ◽  
E. Adam ◽  
M. Lyon ◽  
F. Depontieu ◽  
V. Motte ◽  
...  
1992 ◽  
Vol 6 (3) ◽  
pp. 223-229
Author(s):  
Anna Porwit ◽  
Birger Christensson ◽  
A. Karolina Palucka ◽  
Charlotta Wickman ◽  
Anna-Lena Petrén ◽  
...  

2014 ◽  
Vol 105 (12) ◽  
pp. 1533-1540 ◽  
Author(s):  
Mohammad T. Alam ◽  
Hiroko Nagao‐Kitamoto ◽  
Noritaka Ohga ◽  
Kosuke Akiyama ◽  
Nako Maishi ◽  
...  

Blood ◽  
2013 ◽  
Vol 121 (7) ◽  
pp. 1229-1237 ◽  
Author(s):  
Natalia Platonova ◽  
Geraldine Miquel ◽  
Birgit Regenfuss ◽  
Said Taouji ◽  
Claus Cursiefen ◽  
...  

Key Points FGF2 is able to directly interact with LYVE-1 and glycosylation of LYVE-1 is important for the interaction with FGF2. LYVE-1 inhibits FGF2-dependent lymphangiogenesis and FGF2 modulates LYVE-1's endogenous expression and reverses the effect of TNFβ.


2017 ◽  
Vol 213 (6) ◽  
pp. 612-618 ◽  
Author(s):  
Mozhdeh Foroozan ◽  
Raheleh Roudi ◽  
Maryam Abolhasani ◽  
Elmira Gheytanchi ◽  
Mitra Mehrazma

Resuscitation ◽  
1996 ◽  
Vol 31 (3) ◽  
pp. S19
Author(s):  
BW Böttiger ◽  
PP Nawroth ◽  
T Böker ◽  
J Motsch ◽  
H Böhrer ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document